Press Releases

First AI-enabled community oncology care solution will help clinicians determine the optimal personalized treatment path for patients across rural Kentucky

DENVER – Dec. 12, 2024 – VieCure Inc., pioneer of next-generation intelligence platforms that democratize community oncology care, today announced that Commonwealth Cancer Center in Kentucky will deploy its Halo Intelligence platform, the first AI-enabled community oncology care solution that combines clinical decision support and smart electronic medical records. Clinicians at Commonwealth Cancer Center will use the Halo Intelligence platform to manage the rapidly growing volume of precision oncology data and identify the most effective treatment for each patient’s unique cancer profile.

Commonwealth Cancer Center features a network of highly specialized cancer physicians, advanced practitioners, nurses, and therapists. It offers comprehensive and technologically advanced cancer care to central and southeastern Kentucky communities, where patients would otherwise have to travel great distances to receive treatment. VieCure’s Halo Intelligence platform will allow clinicians at Commonwealth Cancer Center to address the complexities of precision oncology data and use actionable multi-omic information to improve patient outcomes.

“Commonwealth Cancer Center strives to provide the highest level of care for patients across neighborhoods and rural communities of Kentucky,” said Erin Wilcher, Executive Director at Commonwealth Cancer Center. “With the VieCure Halo Intelligence Platform, we gain access to a complete, industry-leading, AI-enabled platform that will allow us to develop personalized treatment plans that are grounded in science, nurtured in compassion, and fueled by our drive to understand and treat cancer in its many forms.”

The complete VieCure platform is an integrated ecosystem of tools, including an oncology information management system, an AI engine, mobile patient and physician apps, a codified content library, and a modern analytics data environment. The dynamic Halo Intelligence platform connects every element essential for diagnostics and treatment centered around the patient-physician interaction, encompassing patient data, physician notes, clinical records, treatment responses, radiology images, pathology-based tumor profiles, and molecular features. The result is a seamless integration of AI and clinician expertise, delivering real-time insights that enhance workflows, improve patient engagement, and lead to better outcomes. 

“This collaboration with Commonwealth Cancer Center underscores our shared dedication to advancing precision oncology and improving patient care in community settings,” said Tony Romano, Vice President and General Manager at VieCure. “We are looking forward to helping this highly regarded team harness the power of their data, democratize community oncology care, and improve outcomes for the many patients they serve.”

For more information on the Halo Intelligence platform, please visit 

https://www.viecure.com/the-platform.

About VieCure

VieCure is the leading provider of next-generation intelligence platforms for community oncology care. Its Halo Intelligence platform is the first AI-enabled clinical decision support and smart electronic medical record platform to assist clinicians in managing a patient's personalized treatment plan throughout cancer diagnosis, therapy, and follow-up care. For more information, please visit VieCure.com and connect with the company on LinkedIn.

VieCure, the VieCure logo, and Halo Intelligence are trademarks of VieCure Inc.